Short answer · Medically reviewed summary · Last updated: 2026-05-08
Rheumatic fever is an inflammatory condition that typically follows a group A streptococcal infection, with its historical recognition dating back to the 17th century. While once a leading cause of death and disability in children, our understanding evolved from viewing it as a mysterious "rheumatism" to identifying it as a preventable autoimmune reaction to bacterial infection. When was Rheumatic fever first described? The first clinical descriptions of Rheumatic fever are attributed to Guillaume de Baillou in 1642, who coined the term "rheumatism" to distinguish it from gout.
1 people with Rheumatic Fever have shared their first-person experience on this question at DiseaseMaps.
What is the history of Rheumatic Fever?
History of Rheumatic Fever: when and how it was discovered, and the milestones in research since, medically reviewed.
Rheumatic fever is an inflammatory condition that typically follows a group A streptococcal infection, with its historical recognition dating back to the 17th century. While once a leading cause of death and disability in children, our understanding evolved from viewing it as a mysterious "rheumatism" to identifying it as a preventable autoimmune reaction to bacterial infection.
When was Rheumatic fever first described?
The first clinical descriptions of Rheumatic fever are attributed to Guillaume de Baillou in 1642, who coined the term "rheumatism" to distinguish it from gout. For centuries, it was poorly understood, often grouped with various joint pains, until Dr. William Charles Wells provided the first detailed account of the cardiac complications associated with Rheumatic fever in 1812, noting the "rheumatic heart" phenomenon.
How has the understanding of Rheumatic fever evolved?
For centuries, the cause of Rheumatic fever remained elusive, with many physicians incorrectly attributing it to "damp weather" or lifestyle factors. The breakthrough came in the 1930s and 40s when researchers confirmed the link between Rheumatic fever and preceding group A streptococcal (strep) infections. This shift allowed medicine to move from palliative care to prevention.
What were the major milestones in treatment and prevention?
The landscape of Rheumatic fever management changed forever with the advent of antibiotics and the implementation of public health strategies:
- 1940s-1950s: Penicillin was introduced, proving highly effective at treating streptococcal pharyngitis and preventing the subsequent onset of Rheumatic fever.
- Jones Criteria (1944): Dr. T. Duckett Jones developed standardized diagnostic criteria, which are still used today, to help clinicians accurately identify cases.
- Public Health: Universal screening and rapid treatment of "strep throat" led to a dramatic decline in the disease in developed nations.
How have technology and genetics informed our view?
Modern genetic research has shed light on why only a small percentage of people who contract a strep infection develop Rheumatic fever. Researchers now focus on HLA (human leukocyte antigen) markers, which suggest a genetic predisposition that makes certain individuals' immune systems more likely to cross-react with heart tissue, leading to valvular damage.
Next steps
- Consult a pediatric cardiologist or rheumatologist if you have a history of untreated streptococcal infections.
- Join our community at DiseaseMaps.org to connect with 11 other members sharing their experiences with Rheumatic fever.
- Ensure prompt medical treatment for any persistent sore throat to prevent potential complications.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Rheumatic Fever overview.
- Orphanet: Rare disease database for rheumatic and inflammatory conditions.
- American Heart Association: Historical guidelines on the diagnosis and treatment of Rheumatic Fever.
- PubMed: Peer-reviewed literature on the pathogenesis of post-streptococcal sequelae.
Rheumatic fever (RF), caused by the immune response to the streptococcus, and continues to be a global health problem. It is a systemic inflammatory disease characterized by the presence of lesions that can affect the heart, joints, the nervous system, the skin and the subcutaneous tissue.
Pathogenesis
It affects mostly children between 5 and 15 years.
60% of individuals who present with acute rheumatic fever (ARF) will develop rheumatic heart disease. According to WHO data from 2004, 15.6 million people suffer from heart disease residual incidence is extremely variable according to whether developed countries or not, with highest incidence in Asia, Africa and South america.
Pathophysiology
In genetically predisposed individuals, the strep infection triggers an immune response that causes heart injury, joint, or brain. Is mediated by an immunological reaction. It has demonstrated the presence of antigenic determinants common between the streptococcus and the heart muscle, that suggest cross-reactivity.
The bodies of Aschoff are the characteristic of carditis. Occur inflammatory injury with subsequent fibrosis and calcification that lead to alterations in valvular insufficiency and stenosis.
Symptoms
Classically it is said that the FRA "licks the joints and bites the heart". The arthritis is migratory without sequelae, and cardiac involvement can cause lesions valvular chronic. The symptomatology is variable and can at times be very atypical, which makes it difficult to diagnosis.
Diagnosis
The diagnosis is based on criteria modified from Jones and WHO criteria. There is no pathognomonic test. In 1944 it introduced the criteria of Jones were updated in 1992 by the American Heart Association.
Prophylaxis and treatment
The prophylactic treatment is penicillin, which is essential to preventing heart disease. Penicillin remains the drug of choice to prevent infection, treat the inflammatory process and continue long-term prophylaxis.
Prognosis
Cardiac involvement will mark the long-term prognosis. Arthritis, chorea and cutaneous lesions are self-limited. The forecast is given by the degree of cardiac involvement and valvular lesions residual.
Posted Aug 1, 2017 by MelanieMolina 2050
